{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:56:13Z","timestamp":1760608573437},"reference-count":30,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,7,24]],"date-time":"2009-07-24T00:00:00Z","timestamp":1248393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Anaesthesiol Scand"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:p><jats:bold>Background: <\/jats:bold> The addition of opioid to local anaesthetics has become a well\u2010accepted practice of spinal anaesthesia for caesarean delivery. Successful caesarean delivery anaesthesia has been reported with the use of a low dose of intrathecal hyperbaric ropivacaine coadministered with sufentanil. This prospective, double\u2010blinded study determined the median effective dose (ED50) of intrathecal hyperbaric ropivacaine with and without sufentanil for caesarean delivery, to quantify the sparing effect of sufentanil on the ED50 of intrathecal hyperbaric ropivacaine.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> Sixty\u2010four parturients undergoing elective caesarean delivery with combined spinal\u2013epidural anaesthesia were randomized into two groups: Group R (ropivacaine) and Group RS (ropivacaine plus sufentanil 5\u2003\u03bcg). The initial dose of ropivacaine was 13\u2003mg in Group R and 10\u2003mg in Group RS. The effective dose was defined as a T<jats:sub>6<\/jats:sub> level attained within 10\u2003min and no supplemental epidural anaesthetic required during surgery. Effective or ineffective responses determined, respectively, a 0.3\u2003mg decrease or increase of the dose of ropivacaine for the next patient using an up\u2013down sequential allocation.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> The ED50 of intrathecal ropivacaine was 11.2\u2003mg [confidence interval (CI) 95%: 11.0\u201311.6] in Group R vs. 8.1\u2003mg (CI 95%: 7.8\u20138.3) in Group RS. Motor block was markedly more intense in Group R than in Group RS, and the incidence of shivering was lower in Group RS than in Group R. There were no differences in the onset time of sensory block or motor block, in the incidence of hypotension, nausea and vomiting.<\/jats:p><jats:p><jats:bold>Conclusion: <\/jats:bold> Intrathecal sufentanil 5\u2003\u03bcg produced a 28% reduction of ED50 of intrathecal hyperbaric ropivacaine for caesarean delivery.<\/jats:p>","DOI":"10.1111\/j.1399-6576.2009.02051.x","type":"journal-article","created":{"date-parts":[[2009,7,24]],"date-time":"2009-07-24T10:06:43Z","timestamp":1248430003000},"page":"284-290","source":"Crossref","is-referenced-by-count":31,"title":["Intrathecal sufentanil decreases the median effective dose (ED50) of intrathecal hyperbaric ropivacaine for caesarean delivery"],"prefix":"10.1111","volume":"54","author":[{"given":"X.","family":"CHEN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"QIAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"FU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"LU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"BEIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,2,4]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"521","article-title":"Intrathecal levobupivacaine and ropivacaine for cesarean section. New perspectives","volume":"71","author":"Celleno D","year":"2005","journal-title":"Minerva Anestesiol"},{"key":"e_1_2_6_3_2","first-page":"1346","article-title":"Spinal ropivacaine for cesarean section","volume":"95","author":"Khaw KS","year":"2001","journal-title":"a dose-finding study"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeg077"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003643-200411000-00001"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijoa.2005.06.006"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2005.00864.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2008.01864.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003643-200308000-00007"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeg123"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aem101"},{"key":"e_1_2_6_12_2","first-page":"209","article-title":"[3H]Sufentanil, a superior ligand for mu\u2010opiate receptors","volume":"87","author":"Leysen JE","year":"1983","journal-title":"binding properties and regional distribution in rat brain and spinal cord"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-199708000-00022"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2004.00504.x"},{"key":"e_1_2_6_15_2","first-page":"852","article-title":"Intrathecal fentanyl, sufentanil, or placebo combined with hyperbaric mepivacaine 2% for parturients undergoing elective cesarean delivery","volume":"96","author":"Meininger D","year":"2003","journal-title":"Anesth Analg"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199712000-00020"},{"key":"e_1_2_6_17_2","first-page":"309","article-title":"Low\u2010dose ropivacaine\u2013sufentanil spinal anaesthesia for caesarean delivery","volume":"17","author":"Qian XW","year":"2008","journal-title":"a randomised trial"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2005.04380.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200509000-00025"},{"key":"e_1_2_6_20_2","first-page":"369","article-title":"Alkalinization of local anesthetics. Which block, which local anesthetic?","volume":"20","author":"Capogna G","year":"1995","journal-title":"Reg Anesth"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1965.tb00523.x"},{"key":"e_1_2_6_22_2","volume-title":"Introduction to statistical analysis","author":"Dixon WJ","year":"1983"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeg251"},{"key":"e_1_2_6_24_2","first-page":"274","article-title":"Perioperative analgesia with subarachnoid sufentanil administration","volume":"17","author":"Courtney MA","year":"1992","journal-title":"Reg Anesth"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aei008"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/86.2.241"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.2006.B0992"},{"key":"e_1_2_6_28_2","first-page":"1214","article-title":"Intrathecal fentanyl for prevention of shivering in cesarean section","volume":"88","author":"Techanivate A","year":"2005","journal-title":"J Med Assoc Thai"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1992.tb02114.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00115550-200505000-00007"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00115550-200501000-00005"}],"container-title":["Acta Anaesthesiologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-6576.2009.02051.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-6576.2009.02051.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:07:55Z","timestamp":1698710875000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-6576.2009.02051.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,4]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1399-6576.2009.02051.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-6576.2009.02051.x","archive":["Portico"],"relation":{},"ISSN":["0001-5172","1399-6576"],"issn-type":[{"value":"0001-5172","type":"print"},{"value":"1399-6576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,4]]}}}